86 related articles for article (PubMed ID: 16117818)
1. Erythropoietin administration does not influence the GH--IGF axis or makers of bone turnover in recreational athletes.
Nelson AE; Howe CJ; Nguyen TV; Seibel MJ; Baxter RC; Handelsman DJ; Kazlauskas R; Ho KK
Clin Endocrinol (Oxf); 2005 Sep; 63(3):305-9. PubMed ID: 16117818
[TBL] [Abstract][Full Text] [Related]
2. Demographic factors influencing the GH system: Implications for the detection of GH doping in sport.
Nelson AE; Ho KK
Growth Horm IGF Res; 2009 Aug; 19(4):327-32. PubMed ID: 19481485
[TBL] [Abstract][Full Text] [Related]
3. Influence of demographic factors and sport type on growth hormone-responsive markers in elite athletes.
Nelson AE; Howe CJ; Nguyen TV; Leung KC; Trout GJ; Seibel MJ; Baxter RC; Handelsman DJ; Kazlauskas R; Ho KK
J Clin Endocrinol Metab; 2006 Nov; 91(11):4424-32. PubMed ID: 16912136
[TBL] [Abstract][Full Text] [Related]
4. Combined evaluation of resting IGF-I, N-terminal propeptide of type III procollagen (PIIINP) and C-terminal cross-linked telopeptide of type I collagen (ICTP) levels might be useful for detecting inappropriate GH administration in athletes: a preliminary report.
Sartorio A; Agosti F; Marazzi N; Maffiuletti NA; Cella SG; Rigamonti AE; Guidetti L; Di Luigi L; Muller EE
Clin Endocrinol (Oxf); 2004 Oct; 61(4):487-93. PubMed ID: 15473882
[TBL] [Abstract][Full Text] [Related]
5. The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: Physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score.
Erotokritou-Mulligan I; Eryl Bassett E; Cowan DA; Bartlett C; Milward P; Sartorio A; Sönksen PH; Holt RI
Clin Endocrinol (Oxf); 2010 Apr; 72(4):520-6. PubMed ID: 19650783
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group.
Longobardi S; Keay N; Ehrnborg C; Cittadini A; Rosén T; Dall R; Boroujerdi MA; Bassett EE; Healy ML; Pentecost C; Wallace JD; Powrie J; Jørgensen JO; Saccà L
J Clin Endocrinol Metab; 2000 Apr; 85(4):1505-12. PubMed ID: 10770189
[TBL] [Abstract][Full Text] [Related]
7. Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis.
Parisotto R; Wu M; Ashenden MJ; Emslie KR; Gore CJ; Howe C; Kazlauskas R; Sharpe K; Trout GJ; Xie M
Haematologica; 2001 Feb; 86(2):128-37. PubMed ID: 11224480
[TBL] [Abstract][Full Text] [Related]
8. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
[TBL] [Abstract][Full Text] [Related]
9. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant growth hormone misuse: insulin-like growth factor I and procollagen type III peptide.
Abellan R; Ventura R; Pichini S; Di Giovannandrea R; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
Int J Sports Med; 2006 Dec; 27(12):976-83. PubMed ID: 16612742
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of growth hormone abuse biomarkers and the influence of gender and testosterone: a randomized double-blind placebo-controlled study in young recreational athletes.
Nelson AE; Meinhardt U; Hansen JL; Walker IH; Stone G; Howe CJ; Leung KC; Seibel MJ; Baxter RC; Handelsman DJ; Kazlauskas R; Ho KK
J Clin Endocrinol Metab; 2008 Jun; 93(6):2213-22. PubMed ID: 18381573
[TBL] [Abstract][Full Text] [Related]
11. Biochemical markers of insulin-like growth factor-I misuse in athletes: the response of serum IGF-I, procollagen type III amino-terminal propeptide, and the GH-2000 score to the administration of rhIGF-I/rhIGF binding protein-3 complex.
Guha N; Erotokritou-Mulligan I; Bartlett C; Nevitt SP; Francis M; Bassett EE; Cowan DA; Sönksen PH; Holt RI
J Clin Endocrinol Metab; 2014 Jun; 99(6):2259-68. PubMed ID: 24606087
[TBL] [Abstract][Full Text] [Related]
12. Detection of growth hormone abuse in sport.
Powrie JK; Bassett EE; Rosen T; Jørgensen JO; Napoli R; Sacca L; Christiansen JS; Bengtsson BA; Sönksen PH;
Growth Horm IGF Res; 2007 Jun; 17(3):220-6. PubMed ID: 17339122
[TBL] [Abstract][Full Text] [Related]
13. Detecting growth hormone abuse in athletes.
Bidlingmaier M; Manolopoulou J
Endocrinol Metab Clin North Am; 2010 Mar; 39(1):25-32, vii. PubMed ID: 20122447
[TBL] [Abstract][Full Text] [Related]
14. Intra-individual variation of GH-dependent markers in athletes: comparison of population based and individual thresholds for detection of GH abuse in sports.
Kniess A; Ziegler E; Thieme D; Müller RK
J Pharm Biomed Anal; 2013 Oct; 84():201-8. PubMed ID: 23850935
[TBL] [Abstract][Full Text] [Related]
15. Biomarker detection of rhGH doping: an excretion study.
Jing J; Zhou X; He C; Zhang L; Yang S; Xu Y; Xie M; Yan Y; Su H; Wu M
Drug Test Anal; 2012 Oct; 4(10):739-44. PubMed ID: 23074170
[TBL] [Abstract][Full Text] [Related]
16. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
[TBL] [Abstract][Full Text] [Related]
17. IGF-I abuse in sport: current knowledge and future prospects for detection.
Guha N; Sönksen PH; Holt RI
Growth Horm IGF Res; 2009 Aug; 19(4):408-11. PubMed ID: 19467615
[TBL] [Abstract][Full Text] [Related]
18. Moving one step closer to catching the GH cheats: The GH-2004 experience.
Holt RI; Bassett EE; Erotokritou-Mulligan I; McHugh C; Cowan D; Bartlett C; Sönksen PH;
Growth Horm IGF Res; 2009 Aug; 19(4):346-51. PubMed ID: 19467613
[TBL] [Abstract][Full Text] [Related]
19. Treatment with the oral growth hormone secretagogue MK-677 increases markers of bone formation and bone resorption in obese young males.
Svensson J; Ohlsson C; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Baylink D; Mohan S; Bengtsson BA
J Bone Miner Res; 1998 Jul; 13(7):1158-66. PubMed ID: 9661080
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density in patients with growth hormone deficiency: does a gender difference exist?
Hitz MF; Jensen JE; Eskildsen PC
Clin Endocrinol (Oxf); 2006 Dec; 65(6):783-91. PubMed ID: 17121531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
